Is this your organization?Claim your profile for free to personalize your presence and add a donate button. Learn more

Start Your Claim

Claiming and managing your profile is free. Enter any email you have access to. In the next step, we'll give you a small snippet to place on the organization's website to verify ownership.

Email address

We'll use this to process your claim and send important profile updates.

Need help? Contact us

: Verified by RoundPaper

FY 2024

Verified NonprofitLast Filed 2024EIN 06-1619523

Alliance for Cancer Gene Therapy Inc

STAMFORD, CTNTEE: T30Founded 2001Website

mission statement

Alliance for cancer gene therapy (ACGT) funds the most innovative scientists (continued in SCH o) working to harness the power of cell and gene therapy to transform how cancer is treated and drive momentum toward a cure.

Share this profile

Total Revenue

$3.1M

FY 2024

Program Spending

92.1%

of total expenses

Known Funders

2019–2024 filings

Key Metrics (FY 2024)

The Numbers

$15.7M

Total Assets

$12.2M net

27.39 mo

Operating Reserves

FY 2024

Active Programs

FY 2024

Total Employees

FY 2024

Funding Track Record

Backed by 33 Institutional Funders

$3.3M raised across 98 grants (2019–2024 filings)

Funder Geography

Funders across 14 states (2019–2024 filings)

Institutional Funding by Year

PaidCommittedBoth

Funder	Location	Total Awarded
Swim Across America Inc	CHARLOTTE, NC	$2,145,000
Fjc	NEW YORK, NY	$250,000
Fidelity Investments Charitable Gift Fund	BOSTON, MA	$225,761
Cogan Family Foundation Tr	Boston, MA	$135,000
The Barbara and Edward Netter Foundation	STAMFORD, CT	$126,500
Jewish Community Foundation of San Diego	SAN DIEGO, CA	$59,618
The Weisman Family Foundation	LANTANA, FL	$45,000
Vanguard Charitable Endowment Program	SOUTHEASTERN, PA	$32,000
Raymond James Charitable Endowment Fund	ST PETERSBURG, FL	$30,000
S & L Marx Foundation Inc	GREENWICH, CT	$27,500

Total tracked: $3,317,914 across 98 grants (2019–2024 filings)

Totals reflect grants as reported on funder tax returns. Timing may not match recipient revenue: funder and recipient fiscal years often differ, and grants paid by a funder in one year may be recognized by the recipient in a different year.

Programs (FY 2024)

What They Do

$4.9M in expenses

In fiscal 4/30/25, ACGT funded clinical investigator grants awarded to innovative scientists conducting translational research at premier academic institutions in the u.s., each focusing on the development of cancer cell and gene therapies for different cancers, including pancreatic, pediatric, and brain cancers, and cancer metastasis. ACGT continued multi-year collaborations with multi-disciplinary 501(c)(3) organizations focused on cell and gene therapy research. ACGT further convened its annual scientific summit and also increased public awareness of cell and gene therapy research through ACGT's website, social media, and impact reports.

Financial History